Alpha Cognition, Inc. (ACOG)
8.24
+0.09
(+1.10%)
USD |
NASDAQ |
Nov 06, 10:32
Alpha Cognition Net Income (Quarterly) : -8.790M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.790M |
| March 31, 2026 | -6.478M |
| December 31, 2025 | -6.856M |
| September 30, 2025 | -1.318M |
| June 30, 2025 | -13.20M |
| March 31, 2025 | -1.725M |
| December 31, 2024 | -5.659M |
| September 30, 2024 | -1.860M |
| June 30, 2024 | -2.116M |
| March 31, 2024 | -5.003M |
| December 31, 2023 | -5.797M |
| September 30, 2023 | -3.269M |
| June 30, 2023 | -2.818M |
| March 31, 2023 | -1.906M |
| Date | Value |
|---|---|
| December 31, 2022 | -4.081M |
| September 30, 2022 | -2.075M |
| June 30, 2022 | -3.004M |
| March 31, 2022 | -2.913M |
| December 31, 2021 | -3.150M |
| September 30, 2021 | -4.289M |
| March 31, 2021 | -12.22M |
| January 31, 2021 | -0.1229M |
| January 31, 2020 | -0.0066M |
| October 31, 2019 | -0.0143M |
| July 31, 2019 | -0.0421M |
| April 30, 2019 | -0.006M |
| January 31, 2019 | -0.0094M |
| October 31, 2018 | -0.0327M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 53.52M |
| Alnylam Pharmaceuticals, Inc. | 2.167B |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
| Vericel Corp. | 2.206M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 6.093M |
| Total Expenses (Quarterly) | 14.88M |
| EPS Diluted (Quarterly) | -0.4037 |
| Enterprise Value | 136.02M |
| Gross Profit Margin (Quarterly) | 93.10% |
| Profit Margin (Quarterly) | -144.3% |
| Earnings Yield | -13.61% |
| Normalized Earnings Yield | -15.58 |